SCHEMBL20192290

SCHEMBL20192290

CSC(=O)Cc1nc(NC(C)C)cs1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HCAR3 P49019 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ GRM5 P41594 1/20 0.31
▸ GRM1 Q13255 1/20 0.31
▸ CDK5 Q00535 3/20 0.31
▸ CDK5R1 Q15078 3/20 0.31
▸ CCNA2 P20248 2/20 0.31
▸ CDK2 P24941 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12840678 0.83 KMT2A (0.34) ALDH1A1HPGDHSD17B10KMT2ATDP1
SCHEMBL19287187 0.82 CYP1A2 (0.38) ALDH1A1HPGDHSD17B10CYP1A2KMT2A
SCHEMBL18739478 0.81 KMT2A (0.33) ALDH1A1HPGDHSD17B10KMT2ATDP1
SCHEMBL19538511 0.68 CYP1A2 (0.39) ALDH1A1HPGDCYP1A2KMT2ATDP1
SCHEMBL16708654 0.67 HCAR3 (0.36) ALDH1A1HPGDHSD17B10HCAR3GRM5
SCHEMBL20705465 0.66 CYP1A2 (0.37) ALDH1A1HPGDCYP1A2KMT2ATDP1
SCHEMBL12674552 0.65 CDK5 (0.39) ALDH1A1HPGDKMT2ATDP1MEN1
SCHEMBL11188433 0.63 HSD17B10 (0.40) ALDH1A1HPGDHSD17B10KMT2AMEN1
SCHEMBL11095698 0.62 CDK5 (0.32) ALDH1A1KMT2ATDP1MEN1L3MBTL1
SCHEMBL5516186 0.58 ALDH1A1 (0.40) ALDH1A1HPGDHSD17B10CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9982016-B2 NPR-B agonists SHIRE ORPHAN THERAPIES GMBH (DE) 2018-05-29 — — US disclosed
Send feedback